Back to Feed
Fintech▲ 70
Biomerica Announces Medicare Pathway
Globenewswire·
Biomerica has received confirmation from a Medicare Administrative Contractor for individual claim reviews of its inFoods IBS product. This development signifies a crucial step towards establishing a scalable commercialization pathway within the Medicare program. The company and its laboratory partner believe that properly documented claims are well-positioned for reimbursement under the existing $300 CMS rate. This confirmation is a significant milestone, potentially unlocking substantial revenue streams and expanding access to their diagnostic solutions for Medicare beneficiaries.
Tags
healthtech
regulation
Original Source
Globenewswire — www.globenewswire.comRelated in Fintech
X Money Tests Whether Social Commerce Can Hold Consumer Deposits
PYMNTSBeaten-down digital asset treasury names lead crypto stock surge as bitcoin hits
CoinDeskBitcoin retakes $78,000 as Trump declares Hormuz ‘open and ready for business’
The BlockSen. Blumenthal presses DOJ and Treasury on Binance monitor amid Iran sanctions
The Block